πŸ‡ΊπŸ‡Έ FDA
Patent

US 9657099

Anti-glucagon antibodies

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 9657099 (Anti-glucagon antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K2039/54, A61K2039/545